Cancer in the elderly: Pancreatic cancer

Surgical Oncology

Volumn 13, Issue 4, 2004, Pages 201-210

  Shore, Susannah ^a   Vimalachandran, Dale ^a   Raraty, Michael G T ^a   Ghaneh, Paula ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Elderly; Pancreatic cancer; Specialist centre

Indexed keywords

ANTIMICROTUBULE AGENT; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; CA 19-9 ANTIGEN; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; GEMCITABINE; PROTEASOME INHIBITOR; PROTEIN FARNESYLTRANSFERASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

BILE DUCT OBSTRUCTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DUODENUM OBSTRUCTION; ECHOGRAPHY; ELDERLY CARE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENE THERAPY; HUMAN; INTERMETHOD COMPARISON; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 11144286053     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2004.11.001     Document Type: Article

References (126)

1. Ferlay J, Bray FI, Pisani P. Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer, WHO; 2001.
2. www.statistics.gov.uk, Department of Health Cancer Statistics. 2004.
3. SEER Cancer Statistics Review. National Cancer Institute, 2004.
4. A. Haycox Current treatment and optimal patient management in pancreatic cancer Alimentary Pharmacology & Therapeutics 12 1998 949 964
5. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000. The global picture European Journal of Cancer 37 2001 S4 S66
6. E. Fernandez Trends in pancreatic cancer mortality in Europe International Journal of Cancer 57 1994 786 792
7. S.R. Bramhall Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands an epidemiological study British Journal of Surgery 82 1 1995 111 115
8. D.C. Carter Etiology and epidemiology of pancreatic and periampullary cancer M. Trede D.C. Carter Surgery of the pancreas 2nd ed 1997 Churchill Livingstone New York 427 442
9. R.T. Greenlee Cancer Statistics, 2001 Ca-a Cancer Journal for Clinicians 51 6 2001 15 36
10. Cancer Statistics in Japan 2001. Foundation for the promotion of cancer research, 2001. www.ncc.go.jp.
11. S. Bramhall, J. Dunn, and J.P. Neoptolemos Epidemiology of pancreatic cancer H.G. Beger The Pancreas 1998 Blackwell Scientific Boston 889 906
12. A. Jemal Cancer statistics 2002 Ca-a Cancer Journal for Clinicians 52 2002 23 47
13. J.P. Neoptolemos Low mortality following resection for pancreatic and periampullary tumours in 1026 patients British Journal of Surgery 84 1997 1370 1376
14. S. Sener Pancreatic cancer a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database Journal of the American College Surgeons 189 1999 1 7
15. A. Andren-Sandberg, and J.P. Neoptolemos Resection for pancreatic cancer in the new millenium Pancreatology 2 2002 694 696
16. L. Gullo Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis Pancreas 22 2 2001 210 213
17. M. Kalser, J. Barkin, and J. MacIntyre Pancreatic cancer assessment of prognosis by clinical presentation Cancer 56 1985 397 402
18. C. Alvarez Cost-benefit analysis of the work-up for pancreatic cancer American Journal of Surgery 165 1993 53 60
19. T. Okusaka Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings Pancreas 22 3 2001 279 284
20. S. Egawa Clinicopathological aspects of small pancreatic cancer Pancreas 28 3 2004 235 240
21. K.F.D. Kuhlmann Surgical treatment of pancreatic adenocarcinom actual survival and prognostic factors in 343 patients European Journal of Cancer 40 2004 549 558
22. A. Mannell Factors influencing survival after resection for ductal adenocarcinoma of the pancreas Annals of Surgery 203 1986 403 407
23. I. Modolell, L. Guarner, and J.R. Malagelada Vagaries of clinical presentation of pancreatic and biliary tract cancer Annals of Oncology 10 suppl. 4 1999 S82 S84
24. Yalniz M, Pour P. Diabetes mellitus: a risk factor for pancreatic cancer? Langenbecks Archives of Surgery, 2004.
25. S. Coughlin Diabetes mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults American Journal of Epidemiology 159 2004 1160 1167
26. L. Gullo Diabetes and the risk of pancreatic cancer New England Journal of Medicine 331 1994 81 84
27. C. Wilson, and C. Imrie Occult pancreatic cancer with recurrent acute pancreatitis Postgraduate Medical Journal 62 1986 765 767
28. A. Lin, and E. Feller Pancreatic carcinoma as a cause of unexplained pancreatitis Report of 10 cases Annals of Internal Medicine 113 1990 166 167
29. H.T. Lynch Hereditary factors in pancreatic cancer Journal of Hepatobiliary Pancreatic Surgery 9 2002 12 31
30. F. Safi, R. Roscher, and H.-G. Beger Tumour markers in pancreatic cancer. Sensitivity and specificity of CA19-9 Hepato Gastroenterology 36 1989 419 423
31. W. Steinberg The clinical utility of the CA19-9 tumour associated antigen American Journal of Gastroenterology 85 350-55 1990
32. J.-E. Kim Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population Journal of Gastroenterology & Hepatology 19 2 2004 182 186
33. H. Sakahara Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic adenocarcinoma Cancer 57 1986 1324 1326
34. K. Nishida Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and it's significant association with prognosis Journal of Surgical Oncology 71 1999 140 146
35. T. Frebourg The evaluation of CA 19-9 antigen level in early detection of pancreatic cancer. A prospective study of 866 patients Cancer 62 1988 2287 2290
36. N. Sawabu Serum tumour markers and molecular biological diagnosis in pancreatic cancer Pancreas 28 3 2004 263 267
37. H. Ozkan, M. Kaya, and A. Cengiz Comparison of tumur marker CA242 with CA19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer Hepatogastroenterology 50 53 2003 1669 1674
38. J. Louhimo Serum HCGβ and CA72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer Oncology 66 2 2004 126 131
39. J. Koopmann Evaluation of osteopontin as a biomarker for pancreatic adenocarcinoma Cancer Epidemiology Biomarkers & Prevention 13 3 2004 487 491
40. S. Minniti Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma Journal of Clinical Ultrasound 31 4 2003 175 182
41. J.P. Campbell, and S. Wilson Pancreatic neoplasms how useful is evaluation with USS? Radiology 167 1988 341 344
42. N. Balci, and R. Semelka Radiological diagnosis and staging of pancreatic ductal adenocarcinoma European Journal of Radiology 38 2001 105 112
43. T.J. Howard Value of helical computed tomography, angiography and endoscopic ultrasound in determining resectability of periampullary carcinoma American Journal of Surgery 174 1997 237 241
44. M.J. McCarthy Prediction of resectability of pancreatic malignancy by computed tomography British Journal of Surgery 85 1998 320 325
45. A. Soriano Preoperative staging and tumour resectability assessment of pancreatic cancer prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging and angiography American Journal of Gastroenterology 99 3 2004 492 510
46. C. Catalano Pancreatic carcinoma the role of high resolution multi-slice spiral CT in the diagnosis and assessment of resectability European Radiology 13 2003 149 156
47. T. Ichikawa Pancreatic ductal adenocarcinoma preoperative assessment with helical CT versus dynamic MR imaging Radiology 202 1997 655 662
48. P. Legmann Pancreatic tumours comparison of dual phase helical CT and endoscopic sonography American Journal of Roentgenology 170 1998 1315 1322
49. Y. Bronstein Detection of small pancreatic tumours with multiphasic helical CT American Journal of Radiology 182 2004 619 623
50. O. Ishikawa Minute carcinoma of the pancreas measuring 1 cm or less in diameter collective review of Japanese case reports Hepatogastroenterology 46 1999 8 15
51. E. Hanninen Prospective evaluation of pancreatic tumours accuracy of MR imaging with MR cholangiopancreatography and MR angiography Radiology 224 2002 34 41
52. H. Saisho, and T. Yamaguchi Diagnostic imaging for pancreatic cancer Pancreas 28 3 2004 273 278
53. M. Zimny Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma a report of 106 cases European Journal of Nuclear Medicine 24 1997 678 682
54. C. Diederichs FDG PET elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancy Journal of Nuclear Medicine 39 1998 1030 1033
55. P. Shreve Focal fluorine-18-fluorodeoxyglucose accumulation in inflammatory pancreatic disease European Journal of Nuclear Medicine 25 1998 259 264
56. F. Gress Role of EUS in the pre-operative staging of pancreatic cancer a large single centre experience Gastrointestine Endoscopy 50 1999 786 791
57. K. Yasuda Staging of pancreatic carcinoma by endoscopic ultrasonography Endoscopy 25 1993 151 155
58. N. Ahmad EUS in preoperative staging of pancreatic cancer Gastrointestine Endoscopy 52 2000 463 468
59. S. Varadarajulu, and M. Wallace Applications of endoscopic ultrasonography in pancreatic cancer Cancer Control 11 1 2004 15 22
60. M.J. Midwinter Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours British Journal of Surgery 86 1999 189 193
61. H. Mertz EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma Gastrointestine Endoscopy 52 2000 367 371
62. B. Agarwal Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer American Journal of Gastroenterology 99 5 2004 844 852
63. G. Hunt, and D. Faigel Assessment of EUS for diagnosing, staging and determining resectability of pancreatic cancer a revies Gastrointestine Endoscopy 55 2002 232 237
64. N. Ahmed Endosonography is superior to angiography in the pre-operative assessment of vascular involvement among patients with pancreatic carcinoma Journal of Clinical Gastroenterology 32 2001 54 58
65. H. Adamek Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography a prospective controlled study Lancet 356 2000 190 193
66. P. Pasanen A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients Anticancer Research 12 6B 1992 2309 2314
67. B. Glasbrenner Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the preoperative assessment of masses in the pancreatic head Digestive Surgery 17 5 2000 468 474
68. C. Stewart Brush cytology in the assessment of pancreaticobiliary strictures a review of 406 cases Journal of Clinical Pathology 54 2001 449 455
69. S. Linder Aspects of percutaneous fine needle aspiration biopsy in the diagnosis of pancreatic carcinoma American Journal of Surgery 174 1997 303 306
70. S. Loperfido Major early complications from diagnostic and therapeutic ERCP a prospective multicentre study Gastrointestinal Endoscopy 48 1 1998 1 10
71. M. Bilbao Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases Gastroenterology 70 3 1976 314 320
72. P. Davids Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction Lancet 340 1992 1488 1492
73. F. Prat A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct Gastrointestine Endoscopy 47 1998 1 7
74. A. Schmassmann Wallstents versus plastic stents in malignant biliary obstruction effects of stent patency of the first and second stents on patient compliance and survival American Journal of Gastroenterology 91 1996 654 853
75. F. Prat Predictive factors for survival of patients with inoperable malignant distal biliary strictures a practical management guideline Gut 42 1998 76 80
76. R.E. Jimenez, A. Warshaw, and C. Fernandez del Castillo Laparoscopy and peritoneal cytology in the staging of pancreatic cancer Journal of Hepatobiliary Pancreatic Surgery 7 2000 15 20
77. S.D. Leach Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head Surgery 118 1995 472 478
78. A. Warshaw Implications of peritoneal cytology for staging of early pancreatic cancer American Journal of Surgery 161 1991 26 30
79. T. John Laparoscopy with laparoscopic ultrasonography in the TMN staging of pancreatic carcinoma World Journal of Surgery 23 1999 870 881
80. P.P. Schachter The impact of laparoscopy and laparoscopic ultrasonography on the management of pancreatic cancer Archives of Surgery 135 2000 1303 1307
81. H. Doran Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours Digestive Surgery 21 2004 305 313
82. V. Di Carlo Pancreatic resection in elderly patients British Journal of Surgery 85 1998 607 610
83. T. Sohn Pancreaticoduodenectomy in octogenarians Journal of Gastrointestinal Surgery 2 3 1998 207 216
84. R. Janes National patterns of care for pancreatic cancer results of a survey by the commission on cancer Annals of Surgery 223 3 1996 261 272
85. M.L. Krzyzanowska, J.C. Weeks, and C.C. Earle Treatment of locally advanced pancreatic cancer in the real world population-based practices and effectiveness Journal of Clinical Oncology 21 18 2003 3409 3414
86. W. Du Cost analysis of pancreatic carcinoma treatment American Cancer Society 89 9 2000 1917 1924
87. D. Li Pancreatic cancer Lancet 363 2004 1049 1057
88. C.N. Mallinson Chemotherapy in pancreatic cancer results of a controlled, prospective, randomised, multicentre trial British Medical Journal 281 6255 1980 1589 1591
89. K.R. Palmer Chemotherapy prolongs survival in inoperable pancreatic carcinoma British Journal of Surgery 81 6 1994 882 885
90. B. Glimelius Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Annals of Oncology 7 6 1996 593 600
91. P. Bornman Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of the head of the pancreas Lancet 1 1986 69 71
92. J. Andersen Randomised trial of endoscopic prosthesis versus operative bypass in malignant obstructive jaundice Gut 30 8 1989 1132 1135
93. A. Smith Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction Lancet 344 8938 1994 1655 1660
94. H. Shepherd Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct a randomized trial British Journal of Surgery 75 12 1988 1166 1168
95. B.V. Wagensveld Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients British Journal of Surgery 84 1997 1402 1406
96. G. Wong Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer. A randomised controlled trial JAMA 291 9 2004 1092 1099
97. K. Lillemoe Chemical spanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomised trial Annals of Surgery 217 5 1993 447 455
98. A. Pietrabissa Thorascopic splachicectomy for pain relief in unresectable pancreatic cancer Archives of Surgery 135 2000 332 335
99. S. Cullinan A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin Cancer 65 10 1990 2207 2212
100. H.A. Burris Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer a randomized trial Journal of Clinical Oncology 15 6 1997 2403 2413
101. M. Rothenberg A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer Annals of Oncology 7 1996 347 353
102. J. Berlin A phase III study of gemcitabine in combination with 5-FU vs. gemcitabine alone in patients with advanced pancreatic carcinoma Eastern Cooperative Oncology Group (E2297) Journal of Clinical Oncology 20 15 2002 3270 3275
103. C. Louvet Gemcitabine combined with oxaloplatin in advanced pancreatic adenocarcinoma final results of a GERCOR multicenter Phase II study Journal of Clinical Oncology 20 6 2002 1512 1518
104. C.M. Rocha Lima Irinotecan plus gemcitabine induces both radiographic and CA19-9 tumour marker responses in patients with previously untreated advanced pancreatic cancer Journal of Clinical Oncology 20 5 2002 1182 1191
105. Shore S, et al. Review Article: Chemotherapy for Pancreatic Cancer. Alimentary Pharmacology & Therapeutics, 2004.
106. W. Kausch Carcinom der papilla duodeni und seine radikale Entfernung Beitrage Klinikund Chirurgiae 78 1912 439 486
107. A. Whipple Observations on radical surgery for lesions of pancreas Surgery Gynaecology and Obstetrics 82 1946 623 631
108. K. Watson Carcinoma of the ampulla of vater successful radical resection British Journal of Surgery 31 1944 368 373
109. A. Lightner Pancreatic resection in the elderly Journal of the American College Surgery 198 5 2004 697 706
110. Y. Fong Pancreatic or liver resection for malignancy is safe and effective for the elderly Annals of surgery 222 4 1995 426 434
111. E. Finlayson, P. Goodney, and J. Birkmeyer Hospital volume and operative mortality in cancer surgery a national study Archives of Surgery 138 2003 721 725
112. K. Al-Sharaf, A. Andren-Sandberg, and I. Ihse Subtotal pancreatectomy for cancer can be safe in the elderly European Journal of Surgery 165 3 1999 230 235
113. F. Mosca Long-term survival in pancreatic cancer pylorus-preserving versus Whipple pancreatoduodenectomy Surgery 122 3 1997 553 566
114. J.H. Allema Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region Cancer 75 8 1995 2069 2076
115. D. Allison DNA content and other factors associated with ten year survival after resection of pancreatic cancinoma Journal of Surgery and Oncology 67 1998 151 159
116. S. Nitecki Long term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Annals of Surgery 221 1995 59 66
117. C.J. Yeo Pancreaticoduodenectomy for pancreatic adenocarcinoma postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Annals of Surgery 225 5 1997 621 633 discussion 633-6
118. H. Schmidt Pancreaticoduodenectomy a 20 year experience in 516 patients Archives of surgery 139 2004 718 727
119. M. Wagner Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma British Journal of Surgery 91 2004 586 594
120. S.P. Cleary Prognostic factors in resected pancreatic adenocarcinoma analysis of actual 5-year survivors Journal of the American College of Surgeons 198 5 2004 722 731
121. J.P. Neoptolemos Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Annals of Surgery 234 6 2001 758 768
122. K.E. Bakkevold Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study European Journal of Cancer 29A 5 1993 698 703
123. J. Neoptolemos A randomised trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer New England Journal of Medicine 350 12 2004 1200 1210
124. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Archives of Surgery 120 8 1985 899 903
125. H.O. Douglas Jr Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group Cancer 59 12 1987 2006 2010
126. I. Yusoff Preoperative assessment of pancreatic malignancy using endoscopic ultrasound Abdominal Imaging 28 4 2003 556 562